Abstract
Covid-19 mitigation commonly involves social distancing. Due to its high economic toll and its impact on personal freedom, we need to ease social distancing and deploy alternative measures, while preventing a second wave of infections. Bluetooth app-based contact tracing has been proposed, focusing on symptomatic cases and isolating their contacts. However, this approach would miss many transmissions by asymptomatic cases. To improve effectiveness of app-based mitigation, we propose to complement contact tracing with Smart Testing relying on Contact Counting (STeCC). STeCC focuses virus RNA testing to people with exceptionally high numbers of contacts. These people are at particularly high risk to become infected (with or without symptoms) and transmit the virus. Mathematical modeling shows that a mitigation strategy combining STeCC and contact tracing in one app will be more efficient than contact tracing and works when ≈50% (instead of ≥60%) of the total population participate. Similarly, it requires 50-100 fold less tests than randomized virus testing alone. These gains in efficiency may be critical for success. STeCC could be integrated in the current Bluetooth tracing apps. Thus, STeCC is technically feasible and can reduce the pandemic’s reproduction number by 2.4-fold (e.g. from R0=2.4 to Reff=1) with realistic test numbers (≈166 per 100’000 people per day), when a realistic fraction of the population would use the app (i.e. ≈50% in total population). Thereby, STeCC efficiently complements the portfolio of mitigation strategies, which allow easing social distancing without compromising public health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
HG acknowledges funding from the Swiss National Science Foundation (grant number 174060).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Added implementation scenarios for STeCC, including an encryption approach to implement STeCC in app-based contact tracing while preserving privay.
Data Availability
All data used for preparation of this manuscript is publicly available.
